To explore effectiveness of procalcitonin-guided antibiotic therapy in acute exacerbations of bronchiectasis, and to explore the clinical value of procalcitonin in bronchiectasis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
210
The application of antimicrobial agents is determined by PCT results.
The application of antimicrobial agents is determined by clinical experience of doctors.
Antimicrobial prescription rate
Time frame: 14 days
Number of days of antimicrobial application
Time frame: 14 days
The number of days in hospital
Time frame: 14 days
Effective rate of clinical treatment
Time frame: 14 days
Quality of life score
Time frame: 6 months
Adverse reaction rate
Time frame: 14 days
Bacterial resistance rate
Time frame: 14 days
The incidence of complications
Time frame: 14 days
fungal infection rate
Time frame: 14 days
mortality rate
Time frame: 14 days
The proportion of patients with at least once acute exacerbation in 6 months
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.